Implications of early airflow decline after myeloablative allogeneic stem cell transplantation

Bone Marrow Transplantation

Volumn 33, Issue 7, 2004, Pages 759-764

  Chien, J W ^a   Martin, P J ^a   Flowers, M E ^a   Nichols, W G ^a   Clark, J G ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Airflow obstruction; Bronchiolitis obliterans; Hematopoietic stem cell transplant

Indexed keywords

ADOLESCENT; ADULT; AIRFLOW; AIRWAY OBSTRUCTION; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CONFIDENCE INTERVAL; EARLY DIAGNOSIS; FEMALE; FORCED EXPIRATORY VOLUME; GRAFT VERSUS HOST REACTION; HUMAN; LUNG FUNCTION TEST; MALE; MORTALITY; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY VENTILATION; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 12944284177     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704422     Document Type: Article

References (31)

1. Chien JW, Martin PJ, Gooley TA et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2003; 168: 208-214.
2. Tait RC, Burnett AK, Robertson AG et al. Subclinical pulmonary function defects following autologous and allogeneic bone marrow transplantation: relationship to total body irradiation and graft-versus-host disease. Int J Radiat Oncol Biol Phys 1991; 20: 1219-1227.
3. Beinert T, Dull T, Wolf K et al. Late pulmonary impairment following allogeneic bone marrow transplantation. Eur J Med Res 1996; 1: 343-348.
4. Schwarer AP, Hughes JM, Trotman-Dickenson B, Krausz T, Goldman JM. A chronic pulmonary syndrome associated with graft-versus-host disease after allogeneic marrow transplantation. Transplantation 1992; 54: 1002-1008.
5. Duncker C, Dohr D, Harsdorf S et al. Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcome. Bone Marrow Transplant 2000; 25: 1263-1268.
6. Chan CK, Hyland RH, Hutcheon MA et al. Small-airways disease in recipients of allogeneic bone marrow transplants. An analysis of 11 cases and a review of the literature. Medicine (Baltimore) 1987; 66: 327-340.
7. Curtis DJ, Smale A, Thien F, Schwarer AP, Szer J. Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 16: 169-173.
8. Clark JG, Schwartz DA, Flournoy N, Sullivan KM, Crawford SW, Thomas ED. Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med 1987; 107: 648-656.
9. Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217.
10. Griese M, Rampf U, Hofmann D, Fuhrer M, Reinhardt D, Bender-Gotze C. Pulmonary complications after bone marrow transplantation in children: twenty-four years of experience in a single pediatric center. Pediatr Pulmonol 2000; 30: 393-401.
11. Paz HL, Crilley P, Patchefsky A, Schiffman RL, Brodsky I. Bronchiolitis obliterans after autologous bone marrow transplantation. Chest 1992; 101: 775-778.
12. Clark JG, Crawford SW, Madtes DK, Sullivan KM. Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann Intern Med 1989; 111: 368-376.
13. Philit F, Wiesendanger T, Archimbaud E, Mornex JF, Brune J, Cordier JF. Post-transplant obstructive lung disease ('bronchiolitis obliterans'): a clinical comparative study of bone marrow and lung transplant patients. Eur Respir J 1995; 8: 551-558.
14. Palmas A, Tefferi A, Myers JL et al. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol 1998; 100: 680-687.
15. Sanchez J, Torres A, Serrano J et al. Long-term follow-up of immunosuppressive treatment for obstructive airways disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 20: 403-408.
16. Hsu KH, Jenkins DE, Hsi BP et al. Ventilatory functions of normal children and young adults - Mexican-American, white, and black. I. Spirometry. J Pediatr 1979; 95: 14-23.
17. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123: 659-664.
18. Folz RJ. Allogeneic stem cell transplant, lung disease, and airflow obstruction. Am J Respir Crit Care Med 2003; 168: 146-147.
19. Koc S, Leisenring W, Flowers ME et al. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood 2002; 100: 48-51.
20. Sullivan K. Graft-versus-host disease. In: Thomas E, Blume K, Forman S (eds). Henatopoietic Stem Cell Transplantation,, 2nd edn. Blackwell Science: Malden, MA, 1999, pp 518-519.
21. Przepiorka D, Smith TL, Folloder J et al. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 1999; 94: 1465-1470.
22. Sullivan KM, Shulman HM, Storb R et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267-276.
23. Nichols WG, Gooley T, Boeckh M. Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience. Biol Blood Marrow Transplant 2001; 7: 11S-15S.
24. Nichols WG, Corey L, Gooley T, Davis C, Boeckh M. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood 2001; 98: 573-578.
25. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998; 280: 1690-1691.
26. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
27. Ralph DD, Springmeyer SC, Sullivan KM, Hackman RC, Storb R, Thomas ED. Rapidly progressive air-flow obstruction in marrow transplant recipients. Possible association between obliterative bronchiolitis and chronic graft-versus-host disease. Am Rev Respir Dis 1984; 129: 641-644.
28. Ostrow D, Buskard N, Hill RS, Vickars L, Churg A. Bronchiolitis obliterans complicating bone marrow transplantation. Chest 1985; 87: 828-830.
29. Johnson FL, Stokes DC, Ruggiero M, Dalla-Pozza L, Callihan TR. Chronic obstructive airways disease after bone marrow transplantation. J Pediatr 1984; 105: 370-376.
30. Epler GR, Colby TV. The spectrum of bronchiolitis obliterans. Chest 1983; 83: 161-162.
31. Badier M, Guillot C, Delpierre S, Vanuxem P, Bla ise D, Maraninchi D. Pulmonary function changes 100 days and one year after bone marrow transplantation. Bone Marrow Transplant 1993; 12: 457-461.